Case Study
⭐ 4.6
Scaling And Replication in Pharmacovigilance for Fortune 500 Firms: A Comparative Perspective
Abstract
This case study investigates “Scaling And Replication in Pharmacovigilance for Fortune 500 Firms: A Comparative Perspective” using a event study methodology. Through a human-centered lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.